avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Klf16
|
ENSMUSG00000035397.8 | Kruppel-like factor 16 |
Sp8
|
ENSMUSG00000048562.6 | trans-acting transcription factor 8 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Klf16 | mm10_v2_chr10_-_80577285_80577327 | -0.82 | 1.1e-09 | Click! |
Sp8 | mm10_v2_chr12_+_118846329_118846329 | 0.04 | 8.1e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_84450944 | 14.05 |
ENSMUST00000085192.5
|
Aldh6a1
|
aldehyde dehydrogenase family 6, subfamily A1 |
chr8_-_93131271 | 13.91 |
ENSMUST00000034189.8
|
Ces1c
|
carboxylesterase 1C |
chr1_+_72824482 | 11.93 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr8_+_105269788 | 10.87 |
ENSMUST00000036127.2
ENSMUST00000163734.2 |
Hsf4
|
heat shock transcription factor 4 |
chr8_+_105269837 | 10.87 |
ENSMUST00000172525.1
ENSMUST00000174837.1 ENSMUST00000173859.1 |
Hsf4
|
heat shock transcription factor 4 |
chr6_-_85869128 | 10.22 |
ENSMUST00000045008.7
|
Cml2
|
camello-like 2 |
chr10_+_63024315 | 10.20 |
ENSMUST00000124784.1
|
Pbld2
|
phenazine biosynthesis-like protein domain containing 2 |
chr10_-_88503952 | 10.13 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr10_+_80329953 | 10.11 |
ENSMUST00000105358.1
ENSMUST00000105357.1 ENSMUST00000105354.1 ENSMUST00000105355.1 |
Reep6
|
receptor accessory protein 6 |
chr12_+_8771405 | 9.98 |
ENSMUST00000171158.1
|
Sdc1
|
syndecan 1 |
chr5_+_134986191 | 9.71 |
ENSMUST00000094245.2
|
Cldn3
|
claudin 3 |
chr12_+_108334341 | 9.05 |
ENSMUST00000021684.4
|
Cyp46a1
|
cytochrome P450, family 46, subfamily a, polypeptide 1 |
chr12_+_8771317 | 9.02 |
ENSMUST00000020911.7
|
Sdc1
|
syndecan 1 |
chr5_-_53213447 | 8.97 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr11_+_94211431 | 8.57 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr19_+_46131888 | 8.54 |
ENSMUST00000043739.3
|
Elovl3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 |
chr7_+_44590886 | 8.45 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr1_+_133363564 | 8.25 |
ENSMUST00000135222.2
|
Etnk2
|
ethanolamine kinase 2 |
chr4_+_141368116 | 8.08 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr8_-_93079965 | 7.88 |
ENSMUST00000109582.1
|
Ces1b
|
carboxylesterase 1B |
chr9_+_47530173 | 7.42 |
ENSMUST00000114548.1
ENSMUST00000152459.1 ENSMUST00000143026.1 ENSMUST00000085909.2 ENSMUST00000114547.1 ENSMUST00000034581.3 |
Cadm1
|
cell adhesion molecule 1 |
chr11_-_120660565 | 7.34 |
ENSMUST00000106177.1
|
Notum
|
notum pectinacetylesterase homolog (Drosophila) |
chr10_+_128194446 | 7.22 |
ENSMUST00000044776.6
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr1_+_74332596 | 7.13 |
ENSMUST00000087225.5
|
Pnkd
|
paroxysmal nonkinesiogenic dyskinesia |
chr4_-_115496129 | 7.11 |
ENSMUST00000030487.2
|
Cyp4a14
|
cytochrome P450, family 4, subfamily a, polypeptide 14 |
chr10_-_88503912 | 6.95 |
ENSMUST00000117579.1
ENSMUST00000073783.5 |
Chpt1
|
choline phosphotransferase 1 |
chr4_+_97777780 | 6.76 |
ENSMUST00000107062.2
ENSMUST00000052018.5 ENSMUST00000107057.1 |
Nfia
|
nuclear factor I/A |
chr7_-_19749464 | 6.71 |
ENSMUST00000075447.7
ENSMUST00000108450.3 |
Pvrl2
|
poliovirus receptor-related 2 |
chr10_+_128194631 | 6.71 |
ENSMUST00000123291.1
|
Gls2
|
glutaminase 2 (liver, mitochondrial) |
chr14_-_61556746 | 6.68 |
ENSMUST00000100496.4
|
Spryd7
|
SPRY domain containing 7 |
chr17_-_32917048 | 6.68 |
ENSMUST00000054174.7
|
Cyp4f14
|
cytochrome P450, family 4, subfamily f, polypeptide 14 |
chr13_-_69611421 | 6.65 |
ENSMUST00000091514.5
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr14_-_33447142 | 6.65 |
ENSMUST00000111944.3
ENSMUST00000022504.5 ENSMUST00000111945.2 |
Mapk8
|
mitogen-activated protein kinase 8 |
chr2_-_168741752 | 6.60 |
ENSMUST00000029060.4
|
Atp9a
|
ATPase, class II, type 9A |
chr4_-_129239165 | 6.52 |
ENSMUST00000097873.3
|
C77080
|
expressed sequence C77080 |
chr7_-_19692596 | 6.46 |
ENSMUST00000108451.2
ENSMUST00000045035.4 |
Apoc1
|
apolipoprotein C-I |
chr11_-_102296618 | 6.44 |
ENSMUST00000107132.2
ENSMUST00000073234.2 |
Atxn7l3
|
ataxin 7-like 3 |
chr13_-_17694729 | 6.42 |
ENSMUST00000068545.4
|
5033411D12Rik
|
RIKEN cDNA 5033411D12 gene |
chrX_-_85776606 | 6.39 |
ENSMUST00000142152.1
ENSMUST00000156390.1 ENSMUST00000113978.2 |
Gyk
|
glycerol kinase |
chr17_-_45686120 | 6.32 |
ENSMUST00000143907.1
ENSMUST00000127065.1 |
Tmem63b
|
transmembrane protein 63b |
chr9_+_46268601 | 6.21 |
ENSMUST00000121598.1
|
Apoa5
|
apolipoprotein A-V |
chr11_+_98348404 | 6.18 |
ENSMUST00000078694.6
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_+_117252010 | 6.14 |
ENSMUST00000125943.1
ENSMUST00000106434.1 |
Tmem53
|
transmembrane protein 53 |
chr1_-_121328024 | 6.13 |
ENSMUST00000003818.7
|
Insig2
|
insulin induced gene 2 |
chr7_+_24481991 | 6.12 |
ENSMUST00000068023.7
|
Cadm4
|
cell adhesion molecule 4 |
chr2_-_130642770 | 6.11 |
ENSMUST00000045761.6
|
Lzts3
|
leucine zipper, putative tumor suppressor family member 3 |
chr8_-_124751808 | 6.10 |
ENSMUST00000055257.5
|
Fam89a
|
family with sequence similarity 89, member A |
chr11_-_74925925 | 6.06 |
ENSMUST00000121738.1
|
Srr
|
serine racemase |
chr17_-_8148097 | 6.04 |
ENSMUST00000097420.5
|
Rnaset2a
|
ribonuclease T2A |
chr4_+_117251951 | 6.00 |
ENSMUST00000062824.5
|
Tmem53
|
transmembrane protein 53 |
chr7_+_44384604 | 5.97 |
ENSMUST00000130707.1
ENSMUST00000130844.1 |
Syt3
|
synaptotagmin III |
chr11_-_70700105 | 5.92 |
ENSMUST00000108543.3
ENSMUST00000108542.1 ENSMUST00000108541.2 ENSMUST00000126114.2 ENSMUST00000073625.1 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr9_+_55326913 | 5.87 |
ENSMUST00000085754.3
ENSMUST00000034862.4 |
AI118078
|
expressed sequence AI118078 |
chr10_-_88504073 | 5.78 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr4_-_148160031 | 5.76 |
ENSMUST00000057907.3
|
Fbxo44
|
F-box protein 44 |
chr16_-_24393588 | 5.76 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr11_+_101468164 | 5.74 |
ENSMUST00000001347.6
|
Rnd2
|
Rho family GTPase 2 |
chr7_-_100658394 | 5.68 |
ENSMUST00000138830.1
ENSMUST00000107044.3 ENSMUST00000116287.2 |
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr15_-_86033777 | 5.68 |
ENSMUST00000016172.7
|
Celsr1
|
cadherin, EGF LAG seven-pass G-type receptor 1 (flamingo homolog, Drosophila) |
chr4_-_114908892 | 5.67 |
ENSMUST00000068654.3
|
Foxd2
|
forkhead box D2 |
chr2_-_160872552 | 5.63 |
ENSMUST00000103111.2
|
Zhx3
|
zinc fingers and homeoboxes 3 |
chr17_+_32506446 | 5.58 |
ENSMUST00000165999.1
|
Cyp4f17
|
cytochrome P450, family 4, subfamily f, polypeptide 17 |
chr11_-_69369377 | 5.56 |
ENSMUST00000092971.6
ENSMUST00000108661.1 |
Chd3
|
chromodomain helicase DNA binding protein 3 |
chr8_+_70072896 | 5.56 |
ENSMUST00000110160.2
ENSMUST00000049197.5 |
Tm6sf2
|
transmembrane 6 superfamily member 2 |
chr13_+_56522497 | 5.54 |
ENSMUST00000045428.6
|
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr9_-_110742577 | 5.52 |
ENSMUST00000006005.7
|
Pth1r
|
parathyroid hormone 1 receptor |
chr9_-_59750616 | 5.49 |
ENSMUST00000163586.1
ENSMUST00000177963.1 ENSMUST00000051039.4 |
Senp8
|
SUMO/sentrin specific peptidase 8 |
chr16_-_20621255 | 5.48 |
ENSMUST00000052939.2
|
Camk2n2
|
calcium/calmodulin-dependent protein kinase II inhibitor 2 |
chr7_+_44816364 | 5.45 |
ENSMUST00000118125.1
|
Il4i1
|
interleukin 4 induced 1 |
chr16_+_44173271 | 5.43 |
ENSMUST00000088356.4
ENSMUST00000169582.1 |
Gm608
|
predicted gene 608 |
chr2_+_155517948 | 5.42 |
ENSMUST00000029135.8
ENSMUST00000065973.2 ENSMUST00000103142.5 |
Acss2
|
acyl-CoA synthetase short-chain family member 2 |
chr14_-_31640878 | 5.41 |
ENSMUST00000167066.1
ENSMUST00000127204.2 ENSMUST00000022437.8 |
Hacl1
|
2-hydroxyacyl-CoA lyase 1 |
chr17_-_45686214 | 5.39 |
ENSMUST00000113523.2
|
Tmem63b
|
transmembrane protein 63b |
chr14_-_61556881 | 5.35 |
ENSMUST00000022497.8
|
Spryd7
|
SPRY domain containing 7 |
chr13_+_54789377 | 5.35 |
ENSMUST00000026993.7
ENSMUST00000131692.2 ENSMUST00000163796.1 |
Tspan17
|
tetraspanin 17 |
chr12_-_104044431 | 5.34 |
ENSMUST00000043915.3
|
Serpina12
|
serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 |
chr5_-_31295862 | 5.32 |
ENSMUST00000041266.7
ENSMUST00000172435.1 |
Fndc4
|
fibronectin type III domain containing 4 |
chr7_-_99626936 | 5.29 |
ENSMUST00000178124.1
|
Gm4980
|
predicted gene 4980 |
chr10_-_128673896 | 5.28 |
ENSMUST00000054764.7
|
Suox
|
sulfite oxidase |
chr11_+_99041237 | 5.27 |
ENSMUST00000017637.6
|
Igfbp4
|
insulin-like growth factor binding protein 4 |
chr5_+_45493374 | 5.26 |
ENSMUST00000046122.6
|
Lap3
|
leucine aminopeptidase 3 |
chr12_+_103532435 | 5.24 |
ENSMUST00000021631.5
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr18_+_64340225 | 5.23 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr7_-_100658364 | 5.20 |
ENSMUST00000107043.1
|
Plekhb1
|
pleckstrin homology domain containing, family B (evectins) member 1 |
chr7_-_44816586 | 5.19 |
ENSMUST00000047356.8
|
Atf5
|
activating transcription factor 5 |
chr2_-_73386396 | 5.17 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr17_-_56074542 | 5.17 |
ENSMUST00000139371.1
|
Ubxn6
|
UBX domain protein 6 |
chr17_+_24736673 | 5.15 |
ENSMUST00000101800.5
|
Msrb1
|
methionine sulfoxide reductase B1 |
chr3_-_89393629 | 5.13 |
ENSMUST00000124783.1
ENSMUST00000126027.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr7_-_140154712 | 5.12 |
ENSMUST00000059241.7
|
Sprn
|
shadow of prion protein |
chr11_-_116198701 | 5.11 |
ENSMUST00000072948.4
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr1_+_193153107 | 5.08 |
ENSMUST00000076521.5
|
Irf6
|
interferon regulatory factor 6 |
chr2_-_148045891 | 5.08 |
ENSMUST00000109964.1
|
Foxa2
|
forkhead box A2 |
chr16_-_46496772 | 5.05 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr11_+_75468040 | 5.04 |
ENSMUST00000043598.7
ENSMUST00000108435.1 |
Tlcd2
|
TLC domain containing 2 |
chrX_-_73716145 | 5.03 |
ENSMUST00000002091.5
|
Bcap31
|
B cell receptor associated protein 31 |
chr1_+_131962941 | 5.02 |
ENSMUST00000177943.1
|
Slc45a3
|
solute carrier family 45, member 3 |
chr10_-_80329426 | 5.02 |
ENSMUST00000020340.8
|
Pcsk4
|
proprotein convertase subtilisin/kexin type 4 |
chr15_+_25622525 | 5.02 |
ENSMUST00000110457.1
ENSMUST00000137601.1 |
Myo10
|
myosin X |
chr1_+_191906743 | 5.01 |
ENSMUST00000044954.6
|
Slc30a1
|
solute carrier family 30 (zinc transporter), member 1 |
chr2_+_102658640 | 4.99 |
ENSMUST00000080210.3
|
Slc1a2
|
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr12_-_30373358 | 4.99 |
ENSMUST00000021004.7
|
Sntg2
|
syntrophin, gamma 2 |
chr5_+_33721724 | 4.99 |
ENSMUST00000067150.7
ENSMUST00000169212.2 ENSMUST00000114411.2 ENSMUST00000164207.3 |
Fgfr3
|
fibroblast growth factor receptor 3 |
chr15_-_76660108 | 4.97 |
ENSMUST00000066677.8
ENSMUST00000177359.1 |
Cyhr1
|
cysteine and histidine rich 1 |
chr2_+_31470207 | 4.95 |
ENSMUST00000102840.4
|
Ass1
|
argininosuccinate synthetase 1 |
chr4_-_117133953 | 4.95 |
ENSMUST00000076859.5
|
Plk3
|
polo-like kinase 3 |
chr4_+_136247932 | 4.92 |
ENSMUST00000102533.4
ENSMUST00000143942.1 |
Tcea3
|
transcription elongation factor A (SII), 3 |
chr7_-_44670820 | 4.91 |
ENSMUST00000048102.7
|
Myh14
|
myosin, heavy polypeptide 14 |
chr9_-_86695897 | 4.90 |
ENSMUST00000034989.8
|
Me1
|
malic enzyme 1, NADP(+)-dependent, cytosolic |
chr7_-_43489967 | 4.88 |
ENSMUST00000107974.1
|
Iglon5
|
IgLON family member 5 |
chr7_+_44384098 | 4.88 |
ENSMUST00000118962.1
ENSMUST00000118831.1 |
Syt3
|
synaptotagmin III |
chr6_-_119848059 | 4.87 |
ENSMUST00000184864.1
|
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr5_+_130448801 | 4.87 |
ENSMUST00000111288.2
|
Caln1
|
calneuron 1 |
chr4_+_97777606 | 4.83 |
ENSMUST00000075448.6
ENSMUST00000092532.6 |
Nfia
|
nuclear factor I/A |
chr8_-_93197799 | 4.81 |
ENSMUST00000034172.7
|
Ces1d
|
carboxylesterase 1D |
chr11_-_116199040 | 4.81 |
ENSMUST00000066587.5
|
Acox1
|
acyl-Coenzyme A oxidase 1, palmitoyl |
chr5_+_73491026 | 4.80 |
ENSMUST00000063882.5
ENSMUST00000113558.1 |
Dcun1d4
|
DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae) |
chr4_+_141242850 | 4.77 |
ENSMUST00000138096.1
ENSMUST00000006618.2 ENSMUST00000125392.1 |
Arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
chr9_-_108263887 | 4.72 |
ENSMUST00000166905.1
ENSMUST00000080435.2 |
Dag1
|
dystroglycan 1 |
chr17_-_28350600 | 4.71 |
ENSMUST00000114799.1
|
Tead3
|
TEA domain family member 3 |
chr3_-_18243289 | 4.71 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr5_+_137569851 | 4.68 |
ENSMUST00000031729.8
|
Tfr2
|
transferrin receptor 2 |
chr12_-_108275409 | 4.65 |
ENSMUST00000136175.1
|
Ccdc85c
|
coiled-coil domain containing 85C |
chr6_-_47813512 | 4.64 |
ENSMUST00000077290.7
|
Pdia4
|
protein disulfide isomerase associated 4 |
chr17_-_28350747 | 4.64 |
ENSMUST00000080572.7
ENSMUST00000156862.1 |
Tead3
|
TEA domain family member 3 |
chr6_+_138140521 | 4.63 |
ENSMUST00000120939.1
ENSMUST00000120302.1 |
Mgst1
|
microsomal glutathione S-transferase 1 |
chr19_+_53903351 | 4.61 |
ENSMUST00000025931.6
ENSMUST00000165617.1 |
Pdcd4
|
programmed cell death 4 |
chr11_+_48838672 | 4.61 |
ENSMUST00000129674.1
|
Trim7
|
tripartite motif-containing 7 |
chr4_-_142015056 | 4.59 |
ENSMUST00000105780.1
|
Fhad1
|
forkhead-associated (FHA) phosphopeptide binding domain 1 |
chr4_+_116877376 | 4.58 |
ENSMUST00000044823.3
|
Zswim5
|
zinc finger SWIM-type containing 5 |
chr1_-_121327672 | 4.56 |
ENSMUST00000159085.1
ENSMUST00000159125.1 ENSMUST00000161818.1 |
Insig2
|
insulin induced gene 2 |
chr7_+_140835018 | 4.56 |
ENSMUST00000106050.1
ENSMUST00000026554.4 |
Urah
|
urate (5-hydroxyiso-) hydrolase |
chr4_+_53011916 | 4.54 |
ENSMUST00000107665.3
|
Nipsnap3b
|
nipsnap homolog 3B (C. elegans) |
chr17_+_28858411 | 4.54 |
ENSMUST00000114737.1
ENSMUST00000056866.5 |
Pnpla1
|
patatin-like phospholipase domain containing 1 |
chr11_-_53430779 | 4.52 |
ENSMUST00000061326.4
ENSMUST00000109021.3 |
Uqcrq
|
ubiquinol-cytochrome c reductase, complex III subunit VII |
chr9_+_46269069 | 4.52 |
ENSMUST00000034584.3
|
Apoa5
|
apolipoprotein A-V |
chr5_+_129941949 | 4.52 |
ENSMUST00000051758.7
ENSMUST00000073945.4 |
Vkorc1l1
|
vitamin K epoxide reductase complex, subunit 1-like 1 |
chr9_+_77754526 | 4.51 |
ENSMUST00000034905.8
|
Gclc
|
glutamate-cysteine ligase, catalytic subunit |
chr7_-_81454751 | 4.47 |
ENSMUST00000098331.3
ENSMUST00000178892.1 |
Cpeb1
|
cytoplasmic polyadenylation element binding protein 1 |
chr4_+_138454305 | 4.46 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_+_4711153 | 4.44 |
ENSMUST00000008991.6
|
Sptbn2
|
spectrin beta, non-erythrocytic 2 |
chr7_-_30924169 | 4.43 |
ENSMUST00000074671.6
|
Hamp2
|
hepcidin antimicrobial peptide 2 |
chr10_+_93488766 | 4.42 |
ENSMUST00000129421.1
|
Hal
|
histidine ammonia lyase |
chr17_-_34959232 | 4.41 |
ENSMUST00000165202.1
ENSMUST00000172753.1 |
Hspa1b
|
heat shock protein 1B |
chr15_-_3583146 | 4.41 |
ENSMUST00000110698.2
|
Ghr
|
growth hormone receptor |
chr15_-_76198147 | 4.40 |
ENSMUST00000072692.4
|
Plec
|
plectin |
chr3_-_107943390 | 4.39 |
ENSMUST00000106681.1
|
Gstm6
|
glutathione S-transferase, mu 6 |
chr15_+_55112317 | 4.39 |
ENSMUST00000096433.3
|
Deptor
|
DEP domain containing MTOR-interacting protein |
chr16_+_22920222 | 4.38 |
ENSMUST00000023587.4
ENSMUST00000116625.2 |
Fetub
|
fetuin beta |
chr16_+_92058270 | 4.37 |
ENSMUST00000047429.8
ENSMUST00000113975.2 |
Mrps6
Slc5a3
|
mitochondrial ribosomal protein S6 solute carrier family 5 (inositol transporters), member 3 |
chr6_-_116193426 | 4.37 |
ENSMUST00000088896.3
|
Tmcc1
|
transmembrane and coiled coil domains 1 |
chr11_-_74925658 | 4.35 |
ENSMUST00000138612.1
ENSMUST00000123855.1 ENSMUST00000128556.1 ENSMUST00000108448.1 ENSMUST00000108447.1 ENSMUST00000065211.2 |
Srr
|
serine racemase |
chr19_+_46761578 | 4.35 |
ENSMUST00000077666.4
ENSMUST00000099373.4 |
Cnnm2
|
cyclin M2 |
chr2_-_33371400 | 4.34 |
ENSMUST00000113164.1
ENSMUST00000091039.2 ENSMUST00000042615.6 |
Ralgps1
|
Ral GEF with PH domain and SH3 binding motif 1 |
chr4_+_53011880 | 4.33 |
ENSMUST00000015391.3
|
Nipsnap3b
|
nipsnap homolog 3B (C. elegans) |
chrX_-_164027965 | 4.32 |
ENSMUST00000033739.4
|
Car5b
|
carbonic anhydrase 5b, mitochondrial |
chr7_+_101321079 | 4.32 |
ENSMUST00000032927.7
|
Stard10
|
START domain containing 10 |
chr9_-_21927515 | 4.30 |
ENSMUST00000178988.1
ENSMUST00000046831.9 |
Tmem205
|
transmembrane protein 205 |
chr6_-_119848120 | 4.29 |
ENSMUST00000183703.1
ENSMUST00000183911.1 |
Erc1
|
ELKS/RAB6-interacting/CAST family member 1 |
chr8_-_123158268 | 4.27 |
ENSMUST00000000755.7
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr7_+_44384803 | 4.27 |
ENSMUST00000120262.1
|
Syt3
|
synaptotagmin III |
chr1_-_121327734 | 4.27 |
ENSMUST00000160968.1
ENSMUST00000162582.1 |
Insig2
|
insulin induced gene 2 |
chr3_-_89393294 | 4.27 |
ENSMUST00000142119.1
ENSMUST00000029677.8 ENSMUST00000148361.1 |
Zbtb7b
|
zinc finger and BTB domain containing 7B |
chr13_+_56522449 | 4.27 |
ENSMUST00000121095.1
ENSMUST00000121871.1 |
Fbxl21
|
F-box and leucine-rich repeat protein 21 |
chr4_-_109202217 | 4.26 |
ENSMUST00000160774.1
ENSMUST00000030288.7 ENSMUST00000162787.2 |
Osbpl9
|
oxysterol binding protein-like 9 |
chr11_+_119942763 | 4.25 |
ENSMUST00000026436.3
ENSMUST00000106231.1 ENSMUST00000075180.5 ENSMUST00000103021.3 ENSMUST00000106233.1 |
Baiap2
|
brain-specific angiogenesis inhibitor 1-associated protein 2 |
chr18_-_56562187 | 4.25 |
ENSMUST00000171844.2
|
Aldh7a1
|
aldehyde dehydrogenase family 7, member A1 |
chr17_-_45685973 | 4.24 |
ENSMUST00000145873.1
|
Tmem63b
|
transmembrane protein 63b |
chr8_-_123158229 | 4.23 |
ENSMUST00000137998.1
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr7_+_68275970 | 4.22 |
ENSMUST00000153805.1
|
Fam169b
|
family with sequence similarity 169, member B |
chr3_+_22076644 | 4.22 |
ENSMUST00000063988.8
|
Tbl1xr1
|
transducin (beta)-like 1X-linked receptor 1 |
chr2_+_164960809 | 4.22 |
ENSMUST00000124372.1
|
Slc12a5
|
solute carrier family 12, member 5 |
chr16_+_44173239 | 4.16 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr16_-_46496955 | 4.16 |
ENSMUST00000023335.6
ENSMUST00000023334.8 |
Pvrl3
|
poliovirus receptor-related 3 |
chr7_-_132576372 | 4.16 |
ENSMUST00000084500.6
|
Oat
|
ornithine aminotransferase |
chr9_+_57697612 | 4.16 |
ENSMUST00000034865.4
|
Cyp1a1
|
cytochrome P450, family 1, subfamily a, polypeptide 1 |
chr1_+_171419027 | 4.16 |
ENSMUST00000171362.1
|
Tstd1
|
thiosulfate sulfurtransferase (rhodanese)-like domain containing 1 |
chr2_-_3419066 | 4.14 |
ENSMUST00000115082.3
|
Meig1
|
meiosis expressed gene 1 |
chr1_+_166254095 | 4.13 |
ENSMUST00000111416.1
|
Ildr2
|
immunoglobulin-like domain containing receptor 2 |
chr5_+_35757875 | 4.13 |
ENSMUST00000101280.3
ENSMUST00000054598.5 ENSMUST00000114205.1 ENSMUST00000114206.2 |
Ablim2
|
actin-binding LIM protein 2 |
chr7_+_28180272 | 4.13 |
ENSMUST00000173223.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr7_+_28180226 | 4.09 |
ENSMUST00000172467.1
|
Dyrk1b
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
chr4_-_107307118 | 4.05 |
ENSMUST00000126291.1
ENSMUST00000106748.1 ENSMUST00000129138.1 ENSMUST00000082426.3 |
Dio1
|
deiodinase, iodothyronine, type I |
chr2_+_156065738 | 4.05 |
ENSMUST00000137966.1
|
Spag4
|
sperm associated antigen 4 |
chr8_+_114133601 | 4.02 |
ENSMUST00000109109.1
|
Nudt7
|
nudix (nucleoside diphosphate linked moiety X)-type motif 7 |
chr13_-_29984219 | 4.02 |
ENSMUST00000146092.1
|
E2f3
|
E2F transcription factor 3 |
chr17_-_56716788 | 4.01 |
ENSMUST00000067931.5
|
Vmac
|
vimentin-type intermediate filament associated coiled-coil protein |
chr11_+_108920342 | 4.01 |
ENSMUST00000052915.7
|
Axin2
|
axin2 |
chr18_-_66002612 | 3.98 |
ENSMUST00000120461.1
ENSMUST00000048260.7 |
Lman1
|
lectin, mannose-binding, 1 |
chr2_-_160872985 | 3.96 |
ENSMUST00000109460.1
ENSMUST00000127201.1 |
Zhx3
|
zinc fingers and homeoboxes 3 |
chr8_-_13974715 | 3.96 |
ENSMUST00000119182.1
ENSMUST00000062613.4 |
Tdrp
|
testis development related protein |
chr7_-_30973464 | 3.94 |
ENSMUST00000001279.8
|
Lsr
|
lipolysis stimulated lipoprotein receptor |
chr11_+_90249469 | 3.90 |
ENSMUST00000004050.6
|
Mmd
|
monocyte to macrophage differentiation-associated |
chr7_+_107595051 | 3.90 |
ENSMUST00000040056.7
|
Ppfibp2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr7_-_119895446 | 3.90 |
ENSMUST00000098080.2
|
Dcun1d3
|
DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae) |
chr17_-_57059795 | 3.89 |
ENSMUST00000040280.7
|
Slc25a23
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 |
chr1_-_121327776 | 3.87 |
ENSMUST00000160688.1
|
Insig2
|
insulin induced gene 2 |
chr4_+_9844349 | 3.86 |
ENSMUST00000057613.2
|
Gdf6
|
growth differentiation factor 6 |
chr5_+_117976761 | 3.85 |
ENSMUST00000035579.6
|
Fbxo21
|
F-box protein 21 |
chr1_+_16105774 | 3.84 |
ENSMUST00000027053.7
|
Rdh10
|
retinol dehydrogenase 10 (all-trans) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 18.0 | GO:0048627 | myoblast development(GO:0048627) |
5.3 | 16.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.8 | 22.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
3.3 | 9.9 | GO:0006507 | GPI anchor release(GO:0006507) |
3.3 | 9.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
3.1 | 9.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
2.9 | 8.7 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
2.7 | 8.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.7 | 8.1 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
2.7 | 10.7 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
2.7 | 10.6 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
2.5 | 10.2 | GO:0030091 | protein repair(GO:0030091) |
2.5 | 9.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
2.4 | 2.4 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
2.3 | 7.0 | GO:1903381 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
2.3 | 9.2 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.3 | 6.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
2.2 | 12.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
2.1 | 6.3 | GO:0070602 | regulation of chondrocyte development(GO:0061181) regulation of centromeric sister chromatid cohesion(GO:0070602) |
2.1 | 6.2 | GO:0009826 | unidimensional cell growth(GO:0009826) |
2.0 | 6.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.0 | 6.0 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
2.0 | 7.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
2.0 | 11.7 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.9 | 7.8 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
1.9 | 5.8 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.9 | 17.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.9 | 5.8 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
1.9 | 5.6 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.8 | 5.5 | GO:0015755 | fructose transport(GO:0015755) |
1.8 | 5.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
1.8 | 1.8 | GO:0098969 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
1.8 | 1.8 | GO:0015744 | succinate transport(GO:0015744) |
1.8 | 10.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.8 | 5.3 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
1.8 | 5.3 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.7 | 8.7 | GO:0015888 | thiamine transport(GO:0015888) |
1.7 | 8.6 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) tyrosine catabolic process(GO:0006572) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.7 | 6.6 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
1.6 | 11.3 | GO:0052805 | imidazole-containing compound catabolic process(GO:0052805) |
1.6 | 6.5 | GO:0032385 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) |
1.6 | 3.2 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.6 | 4.8 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
1.6 | 4.7 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
1.6 | 6.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
1.6 | 7.8 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
1.5 | 6.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
1.5 | 4.6 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
1.5 | 1.5 | GO:0098661 | inorganic anion transmembrane transport(GO:0098661) |
1.5 | 4.5 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.5 | 4.4 | GO:0034334 | adherens junction maintenance(GO:0034334) |
1.5 | 5.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
1.5 | 4.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
1.5 | 17.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
1.5 | 4.4 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
1.5 | 1.5 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
1.5 | 7.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
1.4 | 1.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
1.4 | 11.5 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.4 | 4.3 | GO:0001192 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
1.4 | 14.3 | GO:0061727 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
1.4 | 5.7 | GO:1990401 | embryonic lung development(GO:1990401) |
1.4 | 26.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
1.4 | 1.4 | GO:1905072 | cardiac jelly development(GO:1905072) |
1.4 | 4.1 | GO:0006097 | glyoxylate cycle(GO:0006097) |
1.4 | 4.1 | GO:0061402 | positive regulation of transcription from RNA polymerase II promoter in response to acidic pH(GO:0061402) |
1.4 | 2.7 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
1.3 | 5.3 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.3 | 4.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.3 | 1.3 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
1.3 | 10.5 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
1.3 | 11.8 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.3 | 3.9 | GO:0097274 | urea homeostasis(GO:0097274) |
1.3 | 3.9 | GO:1902617 | response to fluoride(GO:1902617) |
1.3 | 3.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.3 | 6.4 | GO:1901026 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
1.3 | 7.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.3 | 3.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
1.3 | 5.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
1.3 | 2.5 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
1.3 | 11.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
1.3 | 5.0 | GO:0006001 | fructose catabolic process(GO:0006001) response to sucrose(GO:0009744) response to disaccharide(GO:0034285) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.3 | 10.0 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
1.3 | 10.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.2 | 11.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.2 | 3.7 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
1.2 | 3.7 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
1.2 | 2.4 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
1.2 | 3.6 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
1.2 | 3.6 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
1.2 | 3.6 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
1.2 | 7.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
1.2 | 7.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.2 | 3.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.2 | 5.9 | GO:0031437 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
1.2 | 10.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
1.1 | 1.1 | GO:0046710 | GDP metabolic process(GO:0046710) |
1.1 | 1.1 | GO:0007521 | muscle cell fate determination(GO:0007521) |
1.1 | 9.1 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.1 | 4.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
1.1 | 3.4 | GO:0060365 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
1.1 | 7.8 | GO:0030242 | pexophagy(GO:0030242) |
1.1 | 3.4 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
1.1 | 4.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.1 | 3.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
1.1 | 25.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
1.1 | 1.1 | GO:0042117 | monocyte activation(GO:0042117) |
1.1 | 6.4 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
1.1 | 4.2 | GO:0003360 | brainstem development(GO:0003360) |
1.0 | 1.0 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
1.0 | 3.1 | GO:0015866 | ADP transport(GO:0015866) |
1.0 | 3.1 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
1.0 | 1.0 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.0 | 3.1 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
1.0 | 3.0 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.0 | 3.0 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
1.0 | 11.0 | GO:0042448 | progesterone metabolic process(GO:0042448) |
1.0 | 8.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
1.0 | 1.0 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
1.0 | 5.0 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
1.0 | 6.0 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.0 | 6.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.0 | 6.9 | GO:0006108 | malate metabolic process(GO:0006108) |
1.0 | 5.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.0 | 12.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.0 | 5.9 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
1.0 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
1.0 | 2.9 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
1.0 | 3.9 | GO:0097494 | regulation of vesicle size(GO:0097494) |
1.0 | 2.9 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.0 | 5.8 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.9 | 2.8 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.9 | 3.8 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.9 | 8.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 5.6 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.9 | 3.7 | GO:0061760 | antifungal innate immune response(GO:0061760) |
0.9 | 0.9 | GO:0034443 | negative regulation of lipoprotein oxidation(GO:0034443) |
0.9 | 2.8 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.9 | 0.9 | GO:0071287 | cellular response to manganese ion(GO:0071287) |
0.9 | 2.8 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
0.9 | 3.6 | GO:0003165 | Purkinje myocyte development(GO:0003165) |
0.9 | 1.8 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
0.9 | 11.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.9 | 5.4 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.9 | 3.6 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.9 | 6.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.9 | 3.6 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.9 | 2.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.9 | 3.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.9 | 7.1 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.9 | 1.8 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.9 | 5.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.9 | 3.5 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.9 | 2.6 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.9 | 6.1 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.9 | 3.5 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.9 | 13.8 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.9 | 2.6 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.9 | 4.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.9 | 2.6 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.9 | 3.4 | GO:0009227 | UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
0.9 | 2.6 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
0.9 | 2.6 | GO:1903537 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.9 | 2.6 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
0.9 | 0.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.9 | 1.7 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.8 | 7.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.8 | 3.4 | GO:0014028 | notochord formation(GO:0014028) |
0.8 | 3.4 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
0.8 | 5.8 | GO:0015862 | uridine transport(GO:0015862) |
0.8 | 23.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.8 | 2.5 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
0.8 | 3.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.8 | 0.8 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
0.8 | 4.9 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.8 | 1.6 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.8 | 0.8 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.8 | 4.0 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.8 | 3.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.8 | 2.4 | GO:0070342 | brown fat cell proliferation(GO:0070342) regulation of brown fat cell proliferation(GO:0070347) |
0.8 | 3.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.8 | 3.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.8 | 6.2 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 2.3 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.8 | 5.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.8 | 2.3 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.8 | 4.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.8 | 3.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.8 | 2.3 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.8 | 4.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.8 | 3.8 | GO:0072363 | regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072363) |
0.8 | 6.0 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.7 | 3.0 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.7 | 3.0 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.7 | 0.7 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.7 | 7.5 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 1.5 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.7 | 2.2 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 3.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 4.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.7 | 12.5 | GO:0072189 | ureter development(GO:0072189) |
0.7 | 3.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.7 | 2.2 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.7 | 6.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.7 | 8.1 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.7 | 1.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.7 | 7.3 | GO:0031441 | negative regulation of mRNA 3'-end processing(GO:0031441) |
0.7 | 3.6 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.9 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.7 | 10.1 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.7 | 15.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.7 | 2.9 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.7 | 0.7 | GO:0015827 | aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
0.7 | 1.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) regulation of establishment of T cell polarity(GO:1903903) |
0.7 | 0.7 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.7 | 3.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.7 | 2.8 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.7 | 2.8 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
0.7 | 2.8 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.7 | 1.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.7 | 2.1 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.7 | 3.5 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.7 | 4.8 | GO:0001757 | somite specification(GO:0001757) |
0.7 | 8.3 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 2.8 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
0.7 | 2.1 | GO:0018900 | dichloromethane metabolic process(GO:0018900) |
0.7 | 1.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.7 | 2.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.7 | 2.7 | GO:0014732 | skeletal muscle atrophy(GO:0014732) negative regulation of myoblast fusion(GO:1901740) |
0.7 | 2.7 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.7 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 8.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.7 | 1.4 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.7 | 8.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.7 | 12.2 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.7 | 3.4 | GO:1903179 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
0.7 | 2.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.7 | 6.0 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.7 | 2.0 | GO:0061193 | taste bud development(GO:0061193) |
0.7 | 4.6 | GO:0072047 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
0.7 | 2.0 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.7 | 1.3 | GO:0000050 | urea cycle(GO:0000050) |
0.6 | 1.3 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.6 | 0.6 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.6 | 6.4 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.6 | 1.9 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.6 | 0.6 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
0.6 | 1.9 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.6 | 4.4 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.6 | 5.7 | GO:0060613 | fat pad development(GO:0060613) |
0.6 | 6.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 3.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.6 | 4.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.6 | 0.6 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
0.6 | 2.5 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.6 | 2.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.6 | 3.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.6 | 1.2 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.6 | 4.9 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.6 | 4.3 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 3.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.6 | 2.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.6 | 3.1 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.6 | 1.8 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.6 | 10.8 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 4.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.6 | 5.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.6 | 2.4 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.6 | 3.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.6 | 1.8 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.6 | 1.2 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.6 | 2.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.6 | 5.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.6 | 1.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.6 | 2.9 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.6 | 2.3 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.6 | 2.9 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.6 | 6.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.6 | 5.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.6 | 1.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 1.7 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
0.6 | 8.0 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.6 | 4.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.6 | 0.6 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 4.0 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.6 | 3.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.6 | 1.7 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.6 | 2.8 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.6 | 26.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.6 | 7.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.6 | 3.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.6 | 2.3 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.6 | 2.8 | GO:0033762 | response to glucagon(GO:0033762) |
0.6 | 1.7 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.6 | 1.7 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.6 | 3.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.6 | 0.6 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.6 | 1.1 | GO:2000439 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
0.6 | 0.6 | GO:0021502 | neural fold elevation formation(GO:0021502) |
0.5 | 1.6 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.5 | 1.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 2.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.5 | 1.6 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.5 | 12.4 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.5 | 2.1 | GO:0002489 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
0.5 | 0.5 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 1.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.5 | 0.5 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.5 | 2.1 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.5 | 4.2 | GO:1900194 | negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
0.5 | 1.1 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.5 | 1.6 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.5 | 1.6 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.5 | 1.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.5 | 2.6 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
0.5 | 3.7 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 1.0 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.5 | 1.6 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.5 | 3.6 | GO:0009188 | ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.5 | 9.3 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.5 | 1.5 | GO:0031161 | phosphatidylinositol catabolic process(GO:0031161) |
0.5 | 1.5 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.5 | 3.6 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.5 | 1.0 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.5 | 1.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
0.5 | 2.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.5 | 4.1 | GO:0060179 | male mating behavior(GO:0060179) |
0.5 | 2.0 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.5 | 2.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.5 | 2.0 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 3.5 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
0.5 | 1.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.5 | 0.5 | GO:0010845 | regulation of reciprocal meiotic recombination(GO:0010520) positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.5 | 1.5 | GO:0007529 | establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
0.5 | 2.0 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.5 | 3.0 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.5 | 7.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.5 | 8.0 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.5 | 2.0 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.5 | 8.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.5 | 1.5 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.5 | 2.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.5 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.5 | 1.5 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.5 | 0.5 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.5 | 5.9 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.5 | 1.0 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.5 | 1.9 | GO:0060416 | response to growth hormone(GO:0060416) |
0.5 | 3.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.5 | 1.4 | GO:0009397 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.5 | 1.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.5 | 8.6 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.5 | 20.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.5 | 2.4 | GO:1990839 | response to endothelin(GO:1990839) |
0.5 | 6.7 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.5 | 1.4 | GO:0015881 | creatine transport(GO:0015881) |
0.5 | 8.0 | GO:0000338 | protein deneddylation(GO:0000338) |
0.5 | 2.4 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.5 | 1.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.5 | 1.4 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.5 | 1.4 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.5 | 1.4 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.5 | 2.8 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.5 | 1.9 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.5 | 1.9 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.5 | 0.9 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
0.5 | 0.5 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.5 | 1.4 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.5 | 6.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 0.9 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.5 | 6.9 | GO:0046461 | neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
0.5 | 0.9 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.5 | 2.3 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.5 | 2.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.5 | 6.0 | GO:0010225 | response to UV-C(GO:0010225) |
0.5 | 2.3 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.5 | 1.8 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.5 | 4.1 | GO:0051665 | membrane raft localization(GO:0051665) |
0.5 | 11.4 | GO:0080184 | response to phenylpropanoid(GO:0080184) |
0.5 | 0.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.5 | 1.4 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
0.5 | 2.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 2.2 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 2.7 | GO:0098963 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
0.4 | 3.6 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.4 | 3.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.4 | 5.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.4 | 6.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.4 | 2.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.4 | 1.8 | GO:0034769 | basement membrane disassembly(GO:0034769) |
0.4 | 0.4 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.4 | 1.3 | GO:0019405 | alditol catabolic process(GO:0019405) |
0.4 | 7.0 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.4 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 1.8 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.4 | 2.6 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.4 | 0.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.4 | 1.3 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.4 | 2.2 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.4 | 0.9 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.4 | 1.3 | GO:0021843 | substrate-independent telencephalic tangential migration(GO:0021826) interneuron migration from the subpallium to the cortex(GO:0021830) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
0.4 | 1.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.4 | 0.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 0.4 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.4 | 1.7 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.4 | 2.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.4 | 3.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.4 | 13.5 | GO:0071625 | vocalization behavior(GO:0071625) |
0.4 | 1.3 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 1.7 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.4 | 0.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.4 | 1.7 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
0.4 | 1.2 | GO:0043323 | positive regulation of natural killer cell degranulation(GO:0043323) |
0.4 | 1.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.4 | 1.2 | GO:0090382 | phagosome maturation(GO:0090382) |
0.4 | 1.2 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) |
0.4 | 1.7 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.4 | 2.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 1.6 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.4 | 3.3 | GO:0070166 | enamel mineralization(GO:0070166) |
0.4 | 2.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.4 | 3.3 | GO:0021692 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.4 | 2.0 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.4 | 2.5 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.4 | 1.6 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.4 | 1.2 | GO:0033577 | protein glycosylation in endoplasmic reticulum(GO:0033577) |
0.4 | 0.8 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.4 | 6.0 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.4 | 2.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 2.4 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 1.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.4 | 2.4 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 1.6 | GO:0090282 | positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) positive regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0090282) |
0.4 | 1.6 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.4 | 4.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.4 | 0.8 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.4 | 1.2 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.4 | 5.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
0.4 | 3.5 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.4 | 2.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.4 | 5.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.4 | 1.1 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
0.4 | 2.7 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.4 | 1.1 | GO:0014889 | muscle atrophy(GO:0014889) |
0.4 | 1.1 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.4 | 1.1 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.4 | 1.1 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.4 | 4.5 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.9 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.4 | 1.5 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.4 | 1.5 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.4 | 3.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.4 | 1.9 | GO:0021637 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.4 | 0.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.4 | 0.8 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.4 | 1.5 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.4 | 0.7 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.4 | 0.7 | GO:0045818 | negative regulation of glycogen catabolic process(GO:0045818) |
0.4 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 5.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.4 | 1.1 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
0.4 | 2.2 | GO:0098792 | xenophagy(GO:0098792) |
0.4 | 1.1 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.4 | 0.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
0.4 | 0.4 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.4 | 1.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.4 | 4.4 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.4 | 1.1 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.4 | 2.5 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.4 | 1.4 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.4 | 1.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.4 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 0.7 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.4 | 1.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.4 | 2.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.4 | 0.4 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.4 | 1.1 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.4 | 1.4 | GO:0072014 | proximal tubule development(GO:0072014) |
0.3 | 2.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.3 | 0.7 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.3 | 0.3 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.3 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.3 | 1.0 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.3 | 4.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.3 | 3.8 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.3 | 1.0 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.3 | 1.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.3 | 1.4 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.7 | GO:0014850 | response to muscle activity(GO:0014850) |
0.3 | 0.7 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.3 | 1.0 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.3 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.3 | 2.0 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.3 | 1.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 1.3 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.3 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.3 | 1.0 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) positive regulation of cardiac ventricle development(GO:1904414) |
0.3 | 2.0 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.3 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.3 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 0.7 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.3 | 1.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 5.6 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 0.7 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.3 | 1.0 | GO:0051030 | snRNA transport(GO:0051030) |
0.3 | 2.0 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.3 | 0.7 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.3 | 1.0 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 0.7 | GO:1903797 | positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 1.9 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.3 | 9.1 | GO:0048240 | sperm capacitation(GO:0048240) |
0.3 | 1.0 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.3 | 1.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 0.6 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.3 | 1.9 | GO:0070861 | regulation of protein exit from endoplasmic reticulum(GO:0070861) |
0.3 | 0.6 | GO:0009169 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.3 | 0.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 8.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.3 | 1.0 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.0 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
0.3 | 1.9 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.3 | 1.0 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.3 | 2.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 2.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 1.3 | GO:0018317 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 0.6 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 0.3 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.3 | 1.6 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.3 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 0.9 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.3 | 6.1 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 0.9 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 0.9 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 0.6 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) |
0.3 | 2.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 5.8 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.3 | 1.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.9 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.3 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.3 | 1.5 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.3 | 0.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.5 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 0.9 | GO:0048840 | otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
0.3 | 1.8 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.3 | 0.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.3 | 4.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.9 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.3 | 2.0 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 4.7 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.3 | 1.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.3 | 2.9 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.3 | 0.9 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.3 | 0.9 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 1.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 12.0 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.1 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.3 | 0.6 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.3 | 1.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 2.6 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.3 | 3.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.3 | 2.8 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.3 | 1.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.3 | 3.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.6 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 0.6 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.3 | 2.8 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 2.2 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.3 | 0.3 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 1.9 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
0.3 | 0.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.3 | 2.5 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.3 | 1.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.3 | 0.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.3 | 2.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.3 | 0.3 | GO:1904444 | regulation of establishment of Sertoli cell barrier(GO:1904444) |
0.3 | 0.8 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.3 | 6.8 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.3 | 1.1 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.3 | 0.5 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.3 | 0.3 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.3 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 0.3 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.3 | 1.1 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.3 | 3.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.6 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.3 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.3 | 1.6 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.3 | 1.6 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.3 | 0.8 | GO:0016598 | protein arginylation(GO:0016598) |
0.3 | 11.2 | GO:0019835 | cytolysis(GO:0019835) |
0.3 | 0.8 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 1.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 2.9 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 3.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 1.6 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.3 | 0.3 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.3 | 1.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.3 | 1.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.3 | 2.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.3 | 1.0 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.3 | 1.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.3 | 0.3 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.3 | 0.3 | GO:0046337 | phosphatidylethanolamine metabolic process(GO:0046337) |
0.3 | 0.8 | GO:0050973 | detection of mechanical stimulus involved in equilibrioception(GO:0050973) |
0.3 | 1.3 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.3 | 3.1 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.3 | 0.5 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
0.3 | 0.8 | GO:0060785 | regulation of apoptosis involved in tissue homeostasis(GO:0060785) |
0.3 | 2.0 | GO:0015791 | polyol transport(GO:0015791) |
0.3 | 1.0 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.3 | 1.3 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.3 | 1.0 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.3 | 1.0 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.3 | 2.3 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.3 | 1.3 | GO:0030813 | positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.3 | 1.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.5 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.2 | 1.7 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
0.2 | 0.5 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 6.4 | GO:0034063 | stress granule assembly(GO:0034063) |
0.2 | 1.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.2 | 1.7 | GO:0002003 | angiotensin maturation(GO:0002003) |
0.2 | 1.0 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 1.9 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 3.9 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 0.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 2.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 2.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.2 | 1.2 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 1.0 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.5 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.2 | 0.5 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.2 | 1.0 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.2 | 1.4 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.2 | 0.7 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.2 | 1.2 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.2 | 3.8 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 5.4 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.2 | 0.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.2 | 0.7 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
0.2 | 0.5 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
0.2 | 2.8 | GO:2001273 | regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.2 | 1.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.9 | GO:0001842 | neural fold formation(GO:0001842) |
0.2 | 0.2 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.2 | 0.7 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
0.2 | 4.0 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.2 | 2.6 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 4.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.2 | 1.1 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.7 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.2 | 2.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 1.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.2 | 0.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 5.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 0.2 | GO:0043696 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.2 | 1.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 3.3 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.7 | GO:1904717 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.2 | 10.0 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 2.9 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 0.7 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.2 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 2.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 0.2 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.2 | 0.2 | GO:1904020 | regulation of G-protein coupled receptor internalization(GO:1904020) |
0.2 | 3.1 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.2 | 0.7 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.2 | 1.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.2 | 1.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.2 | 1.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 1.3 | GO:0098597 | observational learning(GO:0098597) |
0.2 | 0.2 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.2 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.2 | 1.7 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.2 | 3.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.2 | 1.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.2 | 0.2 | GO:0071609 | chemokine (C-C motif) ligand 5 production(GO:0071609) |
0.2 | 0.8 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.2 | 1.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.2 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 1.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 1.7 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.2 | 1.0 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.2 | 0.2 | GO:0033189 | response to vitamin A(GO:0033189) |
0.2 | 1.9 | GO:0035268 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
0.2 | 1.7 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.2 | 1.7 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 1.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.2 | 1.0 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.2 | 0.2 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.2 | 8.2 | GO:0009060 | aerobic respiration(GO:0009060) |
0.2 | 0.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.2 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.2 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.2 | 1.6 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.2 | 0.2 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.2 | 0.2 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.2 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 1.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.2 | 0.4 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
0.2 | 0.4 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.2 | 0.4 | GO:0060430 | lung saccule development(GO:0060430) |
0.2 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 4.5 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 2.4 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.2 | 2.4 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.2 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.2 | 0.2 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.2 | 0.4 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 3.3 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.2 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 0.2 | GO:0002477 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.2 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 1.9 | GO:0060438 | trachea development(GO:0060438) |
0.2 | 3.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 1.2 | GO:0019217 | regulation of fatty acid metabolic process(GO:0019217) |
0.2 | 0.8 | GO:0009449 | gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.2 | 1.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 1.1 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.2 | 0.8 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 1.3 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.8 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
0.2 | 0.6 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.2 | 1.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.2 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.2 | 1.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.2 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.2 | 1.3 | GO:0097647 | dimeric G-protein coupled receptor signaling pathway(GO:0038042) calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) regulation of collagen catabolic process(GO:0010710) |
0.2 | 1.1 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
0.2 | 0.7 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.2 | 0.7 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 0.6 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.2 | 0.7 | GO:0061744 | motor behavior(GO:0061744) |
0.2 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.2 | 0.6 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.2 | 0.4 | GO:0002266 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.2 | 5.5 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.2 | 1.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.2 | 0.2 | GO:0009838 | abscission(GO:0009838) |
0.2 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.6 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.2 | 0.9 | GO:0072368 | regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.2 | 4.2 | GO:0050962 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.2 | 0.9 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 1.1 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 0.7 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 1.5 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) negative regulation of sodium ion transmembrane transporter activity(GO:2000650) |
0.2 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.2 | 0.9 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 1.8 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.2 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.2 | 0.7 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.2 | 1.1 | GO:1903543 | positive regulation of exosomal secretion(GO:1903543) |
0.2 | 1.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.2 | 0.5 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 0.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.2 | 0.2 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.3 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.2 | 1.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.2 | 0.2 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.2 | 1.7 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.2 | 0.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 1.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.2 | 1.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.2 | 1.2 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.2 | 0.3 | GO:0033483 | gas homeostasis(GO:0033483) nitric oxide homeostasis(GO:0033484) |
0.2 | 0.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 0.7 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 0.3 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 1.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.2 | 0.2 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 4.7 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 7.0 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.2 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.2 | 0.8 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.7 | GO:0002828 | regulation of type 2 immune response(GO:0002828) |
0.2 | 0.7 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
0.2 | 0.5 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.2 | 0.5 | GO:1902961 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.2 | 1.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.5 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 5.3 | GO:0007520 | myoblast fusion(GO:0007520) |
0.2 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.2 | 0.9 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.2 | 0.3 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.2 | 0.9 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 2.0 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.2 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.2 | 0.9 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.2 | 0.3 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.2 | 0.6 | GO:0002188 | translation reinitiation(GO:0002188) |
0.2 | 0.5 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.3 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
0.2 | 0.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.2 | 1.1 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.3 | GO:1903094 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
0.2 | 6.3 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.2 | 0.2 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.2 | 1.5 | GO:1901160 | primary amino compound metabolic process(GO:1901160) |
0.2 | 1.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.2 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.1 | 2.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
0.1 | 0.6 | GO:0002583 | regulation of antigen processing and presentation of peptide antigen(GO:0002583) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
0.1 | 0.1 | GO:0043545 | molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.1 | 0.7 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.1 | 0.1 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.1 | 0.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 2.6 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.1 | 1.2 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 6.0 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.1 | 1.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.3 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.6 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 1.3 | GO:0006465 | signal peptide processing(GO:0006465) |
0.1 | 0.4 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.1 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 3.0 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 2.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 1.7 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.7 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.6 | GO:2000109 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.4 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 1.5 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
0.1 | 3.9 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.3 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 4.4 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 2.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.3 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 2.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 1.9 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
0.1 | 0.4 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.1 | 1.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 3.2 | GO:1902652 | secondary alcohol metabolic process(GO:1902652) |
0.1 | 1.5 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.1 | 1.6 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.7 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 2.6 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 4.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.9 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.6 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 3.3 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.1 | 0.6 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.1 | 0.9 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 0.3 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.1 | 2.4 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 0.5 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.2 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.1 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.4 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.6 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 5.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.1 | 0.2 | GO:0003272 | endocardial cushion formation(GO:0003272) |
0.1 | 2.2 | GO:0060384 | innervation(GO:0060384) |
0.1 | 0.7 | GO:0010575 | positive regulation of vascular endothelial growth factor production(GO:0010575) |
0.1 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.1 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.2 | GO:0034033 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.1 | 0.7 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.1 | 3.4 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.9 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.1 | 0.2 | GO:0010705 | meiotic DNA double-strand break processing(GO:0000706) meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
0.1 | 0.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.2 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
0.1 | 1.2 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.9 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 0.3 | GO:2000074 | regulation of type B pancreatic cell development(GO:2000074) |
0.1 | 0.5 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.1 | 1.3 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 2.0 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.7 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.5 | GO:0099404 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
0.1 | 0.6 | GO:0010613 | positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
0.1 | 1.0 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.7 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.3 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.1 | 1.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.1 | 1.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.1 | 0.4 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.1 | 2.9 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 1.0 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.4 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 1.9 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.6 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.1 | 0.3 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 0.2 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 0.2 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.8 | GO:0048665 | neuron fate specification(GO:0048665) |
0.1 | 1.6 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.1 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 1.5 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.4 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.1 | 0.6 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.4 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 3.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.5 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.2 | GO:0031038 | myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
0.1 | 0.2 | GO:0060618 | nipple development(GO:0060618) |
0.1 | 1.3 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.1 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 1.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.2 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.1 | 0.2 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.4 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.4 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
0.1 | 0.3 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.4 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 1.0 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.8 | GO:0033131 | regulation of glucokinase activity(GO:0033131) regulation of hexokinase activity(GO:1903299) |
0.1 | 0.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 1.7 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.3 | GO:0044028 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.4 | GO:0010286 | heat acclimation(GO:0010286) |
0.1 | 0.7 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.1 | 0.3 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.7 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.3 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.5 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.1 | 0.2 | GO:0072017 | distal tubule development(GO:0072017) |
0.1 | 0.5 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.1 | 0.4 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 0.4 | GO:0002922 | positive regulation of humoral immune response(GO:0002922) |
0.1 | 0.8 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.3 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 1.0 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.1 | 0.9 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.3 | GO:0042640 | anagen(GO:0042640) |
0.1 | 0.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.1 | 4.2 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 0.5 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 0.6 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.1 | 0.8 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.1 | 2.4 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 1.2 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.3 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.1 | 0.1 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.1 | 0.2 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.1 | 0.7 | GO:1902175 | regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902175) |
0.1 | 0.4 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.1 | 0.6 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.1 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.1 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 0.8 | GO:0002021 | response to dietary excess(GO:0002021) |
0.1 | 0.3 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.3 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.2 | GO:0021934 | hindbrain tangential cell migration(GO:0021934) |
0.1 | 0.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.7 | GO:0072329 | monocarboxylic acid catabolic process(GO:0072329) |
0.1 | 0.3 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.1 | 1.6 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.7 | GO:0042311 | vasodilation(GO:0042311) |
0.1 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.1 | GO:2000229 | negative regulation of NAD(P)H oxidase activity(GO:0033861) pancreatic stellate cell proliferation(GO:0072343) regulation of pancreatic stellate cell proliferation(GO:2000229) |
0.1 | 0.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.1 | 0.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.7 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.4 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.1 | 2.9 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 | 0.5 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.4 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.1 | 0.3 | GO:1903332 | regulation of protein folding(GO:1903332) |
0.1 | 0.6 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 1.1 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.1 | 0.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 0.4 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 1.7 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.1 | 0.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.1 | GO:0046104 | thymidine metabolic process(GO:0046104) |
0.1 | 0.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 1.0 | GO:0002347 | response to tumor cell(GO:0002347) |
0.1 | 1.0 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.1 | 0.3 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.1 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.2 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 2.4 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.1 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.3 | GO:0048313 | organelle inheritance(GO:0048308) Golgi inheritance(GO:0048313) |
0.1 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.7 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.6 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.1 | 0.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.1 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.1 | 0.1 | GO:0060220 | camera-type eye photoreceptor cell fate commitment(GO:0060220) |
0.1 | 0.3 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.1 | 0.3 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.1 | 0.3 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.1 | 0.2 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.1 | 0.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.1 | 0.1 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 0.2 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.2 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.1 | 0.4 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.3 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 2.0 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 1.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.0 | 0.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.1 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
0.0 | 0.1 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.0 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.0 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.1 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.0 | 0.0 | GO:0010159 | specification of organ position(GO:0010159) |
0.0 | 0.1 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.0 | 0.2 | GO:0098886 | modification of dendritic spine(GO:0098886) |
0.0 | 0.1 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
0.0 | 0.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.0 | 0.0 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.0 | 0.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.0 | 0.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.0 | 0.3 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.0 | 0.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.3 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.3 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.0 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.3 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.4 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.2 | GO:0050706 | regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.0 | 0.1 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.0 | 0.2 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 3.0 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.5 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.2 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.2 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.0 | GO:0035627 | ceramide transport(GO:0035627) |
0.0 | 0.8 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.0 | 0.1 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.0 | 0.1 | GO:0008595 | blastoderm segmentation(GO:0007350) tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.0 | 0.2 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.0 | 0.5 | GO:0018904 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.1 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.0 | 0.7 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.0 | 0.2 | GO:0002369 | T cell cytokine production(GO:0002369) |
0.0 | 0.0 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.0 | 0.5 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 0.1 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
0.0 | 0.6 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.0 | 0.0 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.0 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
0.0 | 0.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.0 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.1 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.1 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0030035 | microspike assembly(GO:0030035) |
0.0 | 0.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.1 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.0 | GO:0060713 | labyrinthine layer morphogenesis(GO:0060713) |
0.0 | 0.0 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.3 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.0 | 0.1 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 1.1 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.1 | GO:0099515 | actin filament-based transport(GO:0099515) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.8 | 14.4 | GO:0044317 | rod spherule(GO:0044317) |
2.7 | 21.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
2.6 | 5.1 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
2.1 | 6.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
1.7 | 27.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.6 | 8.2 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
1.6 | 25.2 | GO:0070852 | cell body fiber(GO:0070852) |
1.5 | 6.1 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
1.5 | 20.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
1.3 | 4.0 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
1.3 | 18.0 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
1.2 | 4.9 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
1.0 | 5.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.0 | 4.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
1.0 | 5.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.9 | 5.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.9 | 3.4 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.8 | 0.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.8 | 1.7 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 3.4 | GO:1990795 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
0.8 | 1.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.8 | 10.4 | GO:0043219 | lateral loop(GO:0043219) |
0.8 | 6.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 11.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.8 | 2.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.7 | 2.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.7 | 4.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.7 | 5.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.7 | 7.8 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.7 | 5.7 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.7 | 4.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.7 | 5.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.7 | 7.0 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.7 | 4.9 | GO:0070695 | FHF complex(GO:0070695) |
0.7 | 13.9 | GO:0030056 | hemidesmosome(GO:0030056) |
0.7 | 6.9 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 18.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.7 | 0.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
0.7 | 2.7 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.6 | 17.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 3.8 | GO:0044305 | calyx of Held(GO:0044305) |
0.6 | 3.1 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.6 | 8.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.6 | 7.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.6 | 1.8 | GO:0098855 | HCN channel complex(GO:0098855) |
0.6 | 3.0 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.6 | 4.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.6 | 22.5 | GO:0030673 | axolemma(GO:0030673) |
0.6 | 2.3 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 4.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.6 | 4.5 | GO:1990357 | terminal web(GO:1990357) |
0.6 | 2.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 12.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 0.6 | GO:0045275 | respiratory chain complex III(GO:0045275) |
0.5 | 2.7 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.5 | 1.6 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.5 | 9.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.5 | 2.2 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.5 | 0.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.5 | 3.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.5 | 2.2 | GO:1903349 | omegasome membrane(GO:1903349) |
0.5 | 4.3 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 2.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 2.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.5 | 9.0 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.5 | 10.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.5 | 101.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 4.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.5 | 2.0 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.5 | 0.5 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.5 | 3.0 | GO:0097513 | myosin II filament(GO:0097513) |
0.5 | 2.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.5 | 1.0 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.5 | 4.3 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.5 | 1.4 | GO:0097637 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
0.5 | 1.4 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 2.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 0.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.4 | 1.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.4 | 1.3 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 6.1 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.4 | 1.7 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 1.3 | GO:0032783 | ELL-EAF complex(GO:0032783) |
0.4 | 2.0 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 3.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.4 | 2.0 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 48.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.4 | 1.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.4 | 1.5 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 3.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.4 | 1.1 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 2.5 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.4 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
0.4 | 2.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.3 | 1.0 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 18.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.3 | 0.7 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.3 | 2.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 0.7 | GO:0036019 | endolysosome(GO:0036019) |
0.3 | 1.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 2.0 | GO:0036452 | ESCRT I complex(GO:0000813) ESCRT complex(GO:0036452) |
0.3 | 4.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 1.7 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.3 | 1.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 2.3 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 22.6 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 3.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.3 | 81.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 0.6 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
0.3 | 2.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.3 | 3.5 | GO:0061700 | Seh1-associated complex(GO:0035859) GATOR2 complex(GO:0061700) |
0.3 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.3 | 2.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 3.0 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 0.6 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.3 | 1.8 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 3.6 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 9.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.3 | 6.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.3 | 17.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.3 | 3.8 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.3 | 0.9 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.3 | 1.7 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.3 | 6.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.3 | 1.1 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 4.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.3 | 1.1 | GO:0044754 | autolysosome(GO:0044754) |
0.3 | 2.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.3 | 1.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.3 | 0.8 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 0.8 | GO:0070552 | BRISC complex(GO:0070552) |
0.3 | 0.8 | GO:0031417 | NatC complex(GO:0031417) |
0.3 | 14.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 22.1 | GO:0005811 | lipid particle(GO:0005811) |
0.3 | 6.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 1.9 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 0.5 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.3 | 7.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 1.9 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.3 | 4.7 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 8.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.3 | 3.1 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.3 | 5.4 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 2.1 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 0.3 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.3 | 3.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 2.3 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.2 | 0.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 2.2 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.2 | 2.7 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 3.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.2 | 7.0 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 9.5 | GO:0031902 | late endosome membrane(GO:0031902) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 2.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.2 | 0.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 5.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.2 | 0.5 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 2.1 | GO:0036128 | CatSper complex(GO:0036128) |
0.2 | 6.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 8.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.2 | 0.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 3.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 1.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 2.7 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.2 | 4.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 9.4 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 1.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.2 | 0.6 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 3.4 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 2.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.2 | 1.0 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.2 | 1.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 1.0 | GO:0035976 | AP1 complex(GO:0035976) |
0.2 | 1.0 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.2 | 0.6 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 4.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.2 | 2.2 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 0.2 | GO:0042611 | MHC protein complex(GO:0042611) |
0.2 | 0.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 2.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.2 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 2.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 3.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 0.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 1.5 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.5 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.2 | 0.5 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 2.3 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 0.5 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 4.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 1.8 | GO:0005642 | annulate lamellae(GO:0005642) |
0.2 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 1.8 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 48.2 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.2 | 0.5 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 2.9 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.6 | GO:0044194 | cytolytic granule(GO:0044194) |
0.2 | 3.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 3.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.2 | 8.3 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 1.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.2 | 5.4 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 2.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 0.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 2.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 1.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.2 | 0.8 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.9 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.3 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.1 | 0.7 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 0.3 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 11.4 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 6.8 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.1 | 0.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.9 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 3.7 | GO:0031228 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 3.4 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 7.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 1.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 1.9 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 1.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 3.9 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.1 | 19.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.1 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.1 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.3 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 4.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 160.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.9 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 5.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.5 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 0.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 0.7 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 3.3 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.5 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
0.1 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.1 | 5.5 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.6 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.8 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.3 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
0.1 | 8.2 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 0.3 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.9 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 2.4 | GO:0005685 | U1 snRNP(GO:0005685) |
0.1 | 0.5 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.1 | 1.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 0.3 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 12.4 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.1 | 2.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 2.2 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.5 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 18.6 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.3 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 2.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0031533 | mRNA cap methyltransferase complex(GO:0031533) |
0.1 | 11.3 | GO:0005769 | early endosome(GO:0005769) |
0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.1 | 17.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 2.9 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.1 | 0.7 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.1 | 0.8 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.3 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 5.2 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.9 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.1 | 0.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.1 | 0.5 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 0.1 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 11.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.1 | 55.9 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.3 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.0 | 13.5 | GO:0005768 | endosome(GO:0005768) |
0.0 | 0.1 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.0 | 0.9 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.0 | 0.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.2 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0060473 | cortical granule(GO:0060473) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.3 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.5 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.3 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.3 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.0 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.0 | 0.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.0 | 1.6 | GO:0043235 | receptor complex(GO:0043235) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 23.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
4.5 | 13.6 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
3.2 | 9.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
3.2 | 9.5 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
3.1 | 9.3 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
3.1 | 15.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
3.0 | 3.0 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
2.8 | 11.3 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
2.7 | 10.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
2.7 | 8.1 | GO:0046911 | metal chelating activity(GO:0046911) |
2.5 | 15.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
2.5 | 2.5 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
2.5 | 9.9 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
2.4 | 14.2 | GO:0004359 | glutaminase activity(GO:0004359) |
2.3 | 6.9 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
2.3 | 6.8 | GO:0005118 | sevenless binding(GO:0005118) |
2.2 | 13.2 | GO:0004103 | choline kinase activity(GO:0004103) |
2.1 | 10.7 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
2.1 | 4.3 | GO:0070404 | NADH binding(GO:0070404) |
2.1 | 10.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.1 | 6.4 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
2.1 | 6.3 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
2.1 | 8.4 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
2.0 | 2.0 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.0 | 17.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
2.0 | 9.9 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
2.0 | 3.9 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.9 | 5.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
1.9 | 7.4 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
1.8 | 7.4 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
1.8 | 5.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
1.8 | 5.3 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
1.8 | 8.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
1.8 | 10.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
1.7 | 7.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
1.7 | 5.0 | GO:0004454 | ketohexokinase activity(GO:0004454) |
1.7 | 5.0 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.6 | 4.9 | GO:0004473 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
1.6 | 6.5 | GO:1904121 | propanoyl-CoA C-acyltransferase activity(GO:0033814) propionyl-CoA C2-trimethyltridecanoyltransferase activity(GO:0050632) phosphatidylethanolamine transporter activity(GO:1904121) |
1.6 | 6.4 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
1.6 | 14.3 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
1.6 | 4.7 | GO:0004063 | aryldialkylphosphatase activity(GO:0004063) |
1.5 | 6.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.5 | 4.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
1.5 | 1.5 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
1.5 | 5.9 | GO:0019970 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
1.5 | 4.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
1.5 | 17.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
1.5 | 7.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 13.0 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.4 | 4.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
1.3 | 5.4 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.3 | 4.0 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
1.3 | 5.3 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.3 | 7.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.3 | 7.8 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
1.3 | 6.4 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 6.4 | GO:0032810 | sterol response element binding(GO:0032810) |
1.3 | 5.1 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
1.3 | 3.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
1.2 | 3.7 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
1.2 | 4.9 | GO:0042806 | fucose binding(GO:0042806) |
1.2 | 6.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
1.2 | 3.6 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
1.2 | 7.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
1.2 | 10.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
1.2 | 7.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
1.2 | 4.7 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.2 | 3.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.1 | 6.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
1.1 | 2.3 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
1.1 | 5.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.1 | 4.3 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.1 | 3.2 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
1.1 | 4.2 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.1 | 4.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.1 | 5.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
1.0 | 3.1 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
1.0 | 6.2 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
1.0 | 5.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.0 | 4.0 | GO:0008941 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
1.0 | 5.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.9 | 2.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.9 | 2.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.9 | 0.9 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.9 | 2.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.9 | 8.4 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.9 | 3.7 | GO:0004096 | catalase activity(GO:0004096) |
0.9 | 2.8 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.9 | 4.6 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 3.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.9 | 12.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.9 | 3.6 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.9 | 4.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.9 | 3.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.9 | 3.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.8 | 2.5 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
0.8 | 3.3 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.8 | 2.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.8 | 7.1 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.8 | 2.4 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.8 | 4.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.8 | 3.9 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.8 | 2.3 | GO:0030977 | taurine binding(GO:0030977) |
0.8 | 4.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 2.3 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.7 | 3.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.7 | 2.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.7 | 2.9 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.7 | 7.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.7 | 5.7 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.7 | 0.7 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
0.7 | 3.5 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 2.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.7 | 2.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.7 | 0.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.7 | 5.6 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.7 | 4.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.7 | 4.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 3.4 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.7 | 2.1 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.7 | 2.1 | GO:0047651 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
0.7 | 2.1 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.7 | 2.0 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
0.7 | 2.0 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.7 | 2.0 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.7 | 4.1 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 2.7 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.7 | 4.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.7 | 8.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 4.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.7 | 2.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 9.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.6 | 2.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.6 | 0.6 | GO:0055100 | adiponectin binding(GO:0055100) |
0.6 | 4.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.6 | 2.6 | GO:0031699 | beta-3 adrenergic receptor binding(GO:0031699) |
0.6 | 0.6 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 1.9 | GO:0031403 | lithium ion binding(GO:0031403) |
0.6 | 5.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.6 | 4.4 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.6 | 1.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.6 | 3.1 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.6 | 2.5 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.6 | 1.8 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 1.8 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 14.6 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.6 | 6.1 | GO:0039706 | co-receptor binding(GO:0039706) |
0.6 | 4.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.6 | 7.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.6 | 2.4 | GO:0015232 | heme transporter activity(GO:0015232) |
0.6 | 2.4 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 2.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.6 | 1.8 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.6 | 11.7 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.6 | 9.4 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.6 | 2.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.6 | 2.9 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.6 | 1.7 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.6 | 2.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.6 | 1.7 | GO:0001566 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.6 | 2.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.6 | 2.3 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.6 | 1.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.6 | 5.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.6 | 2.8 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.6 | 2.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.6 | 2.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.6 | 6.7 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 1.7 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.6 | 1.7 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
0.6 | 24.8 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.6 | 1.7 | GO:0047874 | dolichyldiphosphatase activity(GO:0047874) |
0.5 | 6.0 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 2.7 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 2.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.5 | 2.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.5 | 2.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.5 | 0.5 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.5 | 1.6 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.5 | 1.1 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 1.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.5 | 11.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.5 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 0.5 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.5 | 26.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.5 | 1.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 3.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.5 | 2.6 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.5 | 4.6 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.5 | 1.5 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.5 | 1.5 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
0.5 | 1.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.5 | 1.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.5 | 1.5 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
0.5 | 1.5 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.5 | 2.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.5 | 1.5 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.5 | 6.9 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.5 | 4.9 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.5 | 1.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.5 | 8.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.5 | 3.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 8.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.5 | 1.4 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.5 | 11.0 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 1.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.5 | 2.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 6.2 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.5 | 2.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 8.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.5 | 1.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.5 | 5.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.5 | 1.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.5 | 1.4 | GO:0070905 | serine binding(GO:0070905) |
0.5 | 1.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.5 | 1.8 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.5 | 0.9 | GO:0001639 | PLC activating G-protein coupled glutamate receptor activity(GO:0001639) G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential(GO:0099530) |
0.5 | 7.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.5 | 5.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.5 | 2.3 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.4 | 1.3 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
0.4 | 2.2 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.4 | 1.3 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.4 | 2.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 12.3 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.4 | 1.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.4 | 1.7 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.4 | 4.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.4 | 9.0 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.4 | 3.8 | GO:0043426 | MRF binding(GO:0043426) |
0.4 | 0.9 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 1.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.4 | 6.8 | GO:0048038 | quinone binding(GO:0048038) |
0.4 | 5.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.4 | 1.7 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.4 | 1.3 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 5.9 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.4 | 1.7 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.2 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 2.1 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.4 | 2.9 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.4 | 2.0 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.4 | 3.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 4.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.4 | 0.4 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.4 | 4.7 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.4 | 9.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 2.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.4 | 12.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.4 | 5.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.4 | 3.1 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 1.1 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.4 | 1.1 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.4 | 1.5 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 0.7 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.4 | 1.1 | GO:0047936 | glucose 1-dehydrogenase [NAD(P)] activity(GO:0047936) |
0.4 | 4.8 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 2.6 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.4 | 3.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.4 | 0.7 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.4 | 1.1 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.4 | 1.8 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.4 | 5.0 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 30.0 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.4 | 1.1 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.4 | 2.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.4 | 2.8 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 1.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.4 | 2.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.4 | 2.1 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.4 | 4.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.3 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.3 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.3 | 2.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.3 | 1.0 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.3 | 1.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 1.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.3 | 6.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.3 | 2.0 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.3 | 5.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 0.7 | GO:0008158 | smoothened binding(GO:0005119) hedgehog receptor activity(GO:0008158) |
0.3 | 8.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 4.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.0 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.3 | 2.3 | GO:0089720 | caspase binding(GO:0089720) |
0.3 | 2.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.3 | 3.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 1.0 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.3 | 6.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.3 | 0.6 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.3 | 2.6 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.3 | 0.6 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.3 | 1.3 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.3 | 0.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 1.9 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 0.6 | GO:0046977 | TAP binding(GO:0046977) |
0.3 | 3.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 24.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 0.9 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
0.3 | 1.5 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.3 | 1.2 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.3 | 1.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.3 | 0.9 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.3 | 1.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 0.6 | GO:1901474 | azole transmembrane transporter activity(GO:1901474) |
0.3 | 2.0 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.3 | 16.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 2.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.3 | 1.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.3 | 0.9 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.3 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 2.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.3 | 3.9 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 5.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 3.1 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.3 | 3.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.3 | 2.8 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.3 | 1.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.3 | 0.8 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 9.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 1.6 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.3 | 0.8 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 1.6 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.3 | 1.0 | GO:0030549 | acetylcholine receptor activator activity(GO:0030549) |
0.3 | 2.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.3 | 1.3 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.3 | 2.3 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.3 | 1.0 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.3 | 5.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.3 | 4.6 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.3 | 1.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.3 | 2.0 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.3 | 0.8 | GO:0072541 | peroxynitrite reductase activity(GO:0072541) |
0.3 | 0.8 | GO:0046964 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.3 | 1.5 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.2 | 1.0 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 4.0 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.2 | 2.5 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.2 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 5.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 1.0 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.2 | 5.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 7.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 1.7 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.2 | 3.8 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.2 | 2.6 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.2 | 6.8 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.7 | GO:0031531 | thyrotropin-releasing hormone receptor binding(GO:0031531) |
0.2 | 4.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 14.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 10.1 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 7.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.2 | 12.0 | GO:0030145 | manganese ion binding(GO:0030145) |
0.2 | 1.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.2 | 4.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.2 | 2.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 1.6 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.2 | 1.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.2 | 6.6 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.2 | 1.3 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.2 | 1.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.2 | 1.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 5.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.2 | 1.1 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 2.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.2 | 1.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 4.0 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 1.7 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 1.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.2 | 8.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.2 | 8.2 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.2 | 0.6 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 3.7 | GO:0004675 | transmembrane receptor protein serine/threonine kinase activity(GO:0004675) |
0.2 | 11.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 3.2 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.6 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.2 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.2 | 9.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 3.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 1.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.2 | 3.9 | GO:0005501 | retinoid binding(GO:0005501) |
0.2 | 2.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 5.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.8 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 1.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.2 | 1.5 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 0.8 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.2 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.6 | GO:0070736 | protein-glycine ligase activity, initiating(GO:0070736) |
0.2 | 1.3 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 2.8 | GO:0016208 | AMP binding(GO:0016208) |
0.2 | 6.8 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.2 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 2.7 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 0.7 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.2 | 0.5 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 5.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 0.5 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) tyrosine 3-monooxygenase activator activity(GO:0036470) L-dopa decarboxylase activator activity(GO:0036478) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 3.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.2 | 0.7 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.2 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 3.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.2 | 0.3 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.2 | 1.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 0.2 | GO:0003681 | bent DNA binding(GO:0003681) |
0.2 | 0.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 3.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 2.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.2 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 1.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.2 | 2.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.2 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.6 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.2 | 2.2 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 0.5 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.2 | 2.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.2 | 3.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.1 | 1.6 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.1 | 0.9 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 3.0 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.4 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 4.1 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 1.2 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.1 | 1.0 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.1 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.7 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 3.7 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.1 | 1.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 2.1 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 0.6 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
0.1 | 7.4 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 2.1 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 0.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.7 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 1.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.7 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.4 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.8 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 2.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 8.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.1 | 1.0 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.1 | 1.5 | GO:0005504 | fatty acid binding(GO:0005504) |
0.1 | 0.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.1 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.1 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 5.7 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.1 | 1.8 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.4 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 0.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 1.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 0.6 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 0.3 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.1 | 2.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 3.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 1.1 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 1.1 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 2.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.9 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.1 | 0.3 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 1.0 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.6 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.5 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 2.1 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.1 | 2.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 2.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.3 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.1 | 0.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 2.3 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 3.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 1.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 0.8 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 3.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 10.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 0.1 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 3.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.3 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
0.1 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.7 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 2.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 0.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.4 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 1.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 3.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.1 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.3 | GO:0008066 | ionotropic glutamate receptor activity(GO:0004970) extracellular-glutamate-gated ion channel activity(GO:0005234) glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.1 | 0.3 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.4 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.3 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.1 | 8.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.5 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 2.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.1 | 3.3 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.1 | 1.3 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.5 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 2.1 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 0.8 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.1 | 0.3 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.6 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.7 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 4.0 | GO:0005253 | anion channel activity(GO:0005253) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 6.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.1 | 0.4 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.1 | 0.2 | GO:0005093 | Rab GDP-dissociation inhibitor activity(GO:0005093) |
0.1 | 0.5 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 4.4 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.1 | 0.2 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 0.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.2 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 1.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.0 | 2.5 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.0 | 0.3 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.5 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.6 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 7.1 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 4.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.1 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.2 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
0.0 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.3 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 1.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 4.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.1 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.1 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.0 | 0.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 14.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.2 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0016433 | rRNA (adenine) methyltransferase activity(GO:0016433) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.2 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.6 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
0.0 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.2 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
0.0 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.1 | GO:0043855 | cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.0 | 0.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 0.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.0 | 0.4 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.0 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.0 | 0.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 1.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.8 | 6.7 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.7 | 16.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.7 | 40.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.6 | 1.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.5 | 19.7 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.5 | 22.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 5.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 0.4 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 3.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 3.6 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 1.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.3 | 17.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.3 | 13.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.3 | 1.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 7.2 | PID ALK1 PATHWAY | ALK1 signaling events |
0.3 | 13.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.3 | 1.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 4.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 5.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.3 | 7.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.2 | 3.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 7.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 12.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 6.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 6.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 10.1 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 15.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.2 | 8.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 3.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 5.9 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 2.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 4.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 7.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.2 | 3.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.2 | 2.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 8.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 8.1 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 1.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 6.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 2.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.2 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 2.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 3.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.6 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 23.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 0.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 6.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.1 | 1.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 0.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 3.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 1.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.1 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 0.9 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 1.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 0.3 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 1.3 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 7.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 1.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.2 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 0.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.1 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.1 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 45.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 1.7 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
1.6 | 35.6 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.4 | 4.2 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
1.3 | 4.0 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.3 | 29.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
1.1 | 32.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.0 | 13.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.9 | 16.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.9 | 9.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.9 | 11.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.9 | 32.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.9 | 16.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.8 | 3.4 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.8 | 15.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.8 | 26.3 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.8 | 13.9 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.8 | 10.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 14.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.7 | 2.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.7 | 7.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.6 | 7.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.6 | 8.6 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.6 | 13.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 8.5 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 4.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.5 | 44.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.5 | 0.5 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.5 | 5.8 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 8.1 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.5 | 5.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.5 | 5.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.5 | 5.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 7.5 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.4 | 5.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.4 | 8.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 4.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.4 | 1.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.4 | 2.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.4 | 7.1 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.4 | 11.4 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.4 | 4.6 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 6.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 8.3 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.4 | 59.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 5.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.4 | 3.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 4.9 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.3 | 13.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.3 | 6.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 3.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.3 | 0.9 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 13.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 5.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.3 | 20.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 1.2 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.3 | 0.9 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 0.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.3 | 1.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.3 | 1.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.3 | 1.1 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.3 | 3.0 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.3 | 4.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.3 | 8.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 3.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.3 | 6.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.3 | 5.6 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 3.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 4.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 4.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 1.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 8.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.2 | 5.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 9.1 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 2.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.2 | 2.5 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.2 | 2.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 5.9 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 4.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 4.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 7.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.2 | 3.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 2.1 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 7.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 4.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 2.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.2 | 3.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 4.2 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 3.4 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.2 | 5.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 3.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.2 | 9.6 | REACTOME BIOLOGICAL OXIDATIONS | Genes involved in Biological oxidations |
0.2 | 2.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 0.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.3 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 2.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 1.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 7.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.2 | 1.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 1.3 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.1 | 1.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 3.5 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 3.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 6.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.7 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.2 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 2.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 3.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 5.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 5.6 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.0 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 1.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.1 | 0.3 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 5.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.1 | 5.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 3.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 6.4 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 3.0 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.2 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 1.0 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 3.6 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 3.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 0.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 2.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.9 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 1.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.2 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 0.2 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.9 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.4 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 1.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 2.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |